Philippe Brasseur
Overview
Explore the profile of Philippe Brasseur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dellicour S, Brasseur P, Thorn P, Gaye O, Olliaro P, Badiane M, et al.
Drug Saf
. 2013 May;
36(7):505-13.
PMID: 23673815
Background: There are insufficient data on the safety in early pregnancy of the artemisinins, a new class of antimalarials. Assessment of drug teratogenicity requires large sample sizes for an adequate...
12.
Ndounga M, Issamou Mayengue P, Casimiro P, Loumouamou D, Basco L, Ntoumi F, et al.
Malar J
. 2013 Feb;
12:53.
PMID: 23384005
Background: Congo-Brazzaville adopted artemisinin-based combination therapy (ACT) in 2006. Artesunate-amodiaquine (AS + AQ) and artemether-lumefantrine are the first-line and second-line anti-malarial drugs to treat uncomplicated Plasmodium falciparum malaria, respectively. The...
13.
Brasseur P, Vaillant M, Olliaro P
Malar J
. 2012 Dec;
11:402.
PMID: 23216982
Background: Knowing the safety profile of anti-malarial treatments in routine use is essential; millions of patients receive now artemisinin combination therapy (ACT) annually, but the return on information through current...
14.
Brasseur P, Badiane M, Cisse M, Agnamey P, Vaillant M, Olliaro P
Malar J
. 2011 Jul;
10:203.
PMID: 21787420
Background: Malaria is reportedly receding in different epidemiological settings, but local long-term surveys are limited. At Mlomp dispensary in south-western Senegal, an area of moderate malaria transmission, year-round, clinically-suspected malaria...
15.
Brasseur P, Agnamey P, Emmanuel E, Pape J, Vaillant M, Raccurt C
Arch Environ Occup Health
. 2011 Feb;
66(1):12-7.
PMID: 21337181
Cryptosporidiosis is one of the most frequent causes of diarrhea in Haiti. Transmission in children less than five years-old, HIV-infected individuals, and people living in low socio-economic conditions is frequently...
16.
Roussilhon C, Brasseur P, Agnamey P, Perignon J, Druilhe P
PLoS One
. 2010 Feb;
5(2):e9309.
PMID: 20174576
Background: Former studies have pointed to a monocyte-dependent effect of antibodies in protection against malaria and thereby to cytophilic antibodies IgG1 and IgG3, which trigger monocyte receptors. Field investigations have...
17.
Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, et al.
Malar J
. 2009 Aug;
8:203.
PMID: 19698172
Background: Artesunate and amodiaquine (AS&AQ) is at present the world's second most widely used artemisinin-based combination therapy (ACT). It was necessary to evaluate the efficacy of ACT, recently adopted by...
18.
Ndiaye J, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, et al.
Malar J
. 2009 Jun;
8:125.
PMID: 19505304
Background: The use of artemisinin derivative-based combination therapy (ACT) such as artesunate plus amodiaquine is currently recommended for the treatment of uncomplicated Plasmodium falciparum malaria. Fixed-dose combinations are more adapted...
19.
Olliaro P, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M, et al.
Malar J
. 2008 Nov;
7:234.
PMID: 18992140
Background: Intermittent preventive treatment with sulphadoxine-pyrimethamine (SP) is recommended for reducing the risk of malaria in pregnancy and its consequences on mothers and babies (IPTp-SP). Indicators of implementation and effects...
20.
Olliaro P, Brasseur P
Bull Acad Natl Med
. 2008 May;
191(7):1285-92.
PMID: 18447050
Prospects for new and effective antimalarial treatments have improved significantly in the past few years. There are more funds, new operational paradigms and actors, and more products in the pipeline....